Certolizumab pegol effectiveness, survival and safety in patients with psoriasis: A multicenter retrospective analysis in daily clinical practice by the Spanish Psoriasis Group

Documenti analoghi

• Dose reduction is a feasible strategy in patients with plaque psoriasis who achieve sustained response with secukinumab: a retrospective, multicenter cohort study in daily practice setting
  di: Esteban Daudén, et al.
  Pubblicazione: (2024)
• Use of Patient Reported Outcome Measurements Information in Clinical Practice in Spain for the Clinical Management of Psoriasis Patients—Summer Project
  di: Jaime Notario, et al.
  Pubblicazione: (2026)
• Certolizumab pegol for plaque psoriasis in women of childbearing potential, pregnant or breastfeeding in clinical settings: One‐year outcomes from the international noninterventional CIMREAL study
  di: Tom Hillary, et al.
  Pubblicazione: (2024)
• Psoriasis dermatitis, a common phenotype of early forms of both psoriasis and atopic dermatitis in children: A prospective multicenter study
  di: Alexandre Docampo‐Simón, et al.
  Pubblicazione: (2024)
• Anti‐IL‐23 therapy for the treatment of moderate‐to‐severe inverse psoriasis: A 52‐week multicenter study
  di: Joan Ceravalls, et al.
  Pubblicazione: (2024)